🔗 Permalink

Inventor profile of:

ALAN CUTHBERTSON

City:

OSLO

Country:

Norway

Published Applications:

59

Last publication date:

2025-10-16

Top Assignees for applications by ALAN CUTHBERTSON

The entities that hold a legal rights for patent applications filed by inventor CUTHBERTSON ALAN:

GE HEALTHCARE AS 25 OSLO, Norway
BAYER AS 10 Oslo, Norway
GE HEALTHCARE LIMITED 5 BUCKINGHAMSHIRE, United Kingdom
GE HEALTHCARE LIMITED 4 LITTLE CHALFONT, United Kingdom
Bayer Aktiengesellschaft 4 Leverkusen, Germany
Bayer Pharma Aktiengesellschaft 3 Berlin, Germany
AMERSHAM HEALTH AS 3 Oslo, Norway
HAMMERSMITH IMANET LIMITED 2 LONDON, United Kingdom
GE Healthcare AS 2 Olso, Norway
GE Healthcare, Inc. 1 Oslo, Norway
GENERAL ELECTRIC COMPANY 1 Schenectady, NY United States
GE HEALTHCARE LIMITED 1 Little Chalfont, Buckinghamshire, United Kingdom
IMPERIAL COLLEGE 1 London, United Kingdom
GE HEALTHCARE LIMITED 1 AMERSHAM, United Kingdom
IMPERIAL COLLEGE 1 SOUTH KENSINGTON, United Kingdom

Recent patent applications by CUTHBERTSON ALAN

ALAN CUTHBERTSON from OSLO, NO has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-16

US20250319216A1

Human necessities

RADIOPHARMCEUTICAL COMPLEXES TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND ITS COMBINATIONS

#2 | 2024-05-16

US20240156999A1

Human necessities

MULTIMERIC CHELATOR COMPOUNDS FOR USE IN TARGETED RADIOTHERAPY

#3 | 2023-03-09

US20230072421A1

Human necessities

TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

#4 | 2022-05-12

US20220143229A1

Human necessities

RADIO-PHARMACEUTICAL COMPLEXES

#5 | 2022-04-28

US20220125960A1

Human necessities

COMBINATION OF PD-1/PD-L1 INHIBITORS AND TARGETED THORIUM CONJUGATES

#6 | 2022-01-27

US20220023449A1

Human necessities

PHARMACEUTICAL PREPARATION

#7 | 2021-10-21

US20210322583A1

Human necessities

RADIO-PHARMACEUTICAL COMPLEXES

#8 | 2021-06-24

US20210187134A1

Human necessities

COMBINATION OF PI3K-INHIBITORS AND TARGETED THORIUM CONJUGATES

#9 | 2020-01-16

US20200016283A1

Human necessities

COMBINATION THERAPY COMPRISING A RADIOPHARMACEUTICAL AND A DNA-REPAIR INHIBITOR

#10 | 2019-10-03

US20190298865A1

Human necessities

RADIO-PHARMACEUTICAL COMPLEXES

#11 | 2019-04-11

US20190105409A9

Human necessities

IMAGING AGENTS WITH IMPROVED PHARMACOKINETIC PROFILES

#12 | 2019-03-28

US20190091354A1

Human necessities

Radio-pharmaceutical complexes

#13 | 2017-11-30

US20170340759A1

Human necessities

RADIO-PHARMACEUTICAL COMPLEXES

#14 | 2016-04-28

US20160114063A1

Human necessities

PHARMACEUTICAL PREPARATION

#15 | 2014-09-25

US20140286866A1

Human necessities

IMAGING AGENTS WITH IMPROVED PHARMACOKINETIC PROFILES

#16 | 2013-12-26

US20130343990A1

Human necessities

Radiolabelled octreotate analogues as PET tracers

#17 | 2013-04-25

US20130101509A1

Human necessities

IMAGING AND RADIOTHERAPY METHODS

#18 | 2012-11-01

US20120275973A1

Chemistry; metallurgy

PURIFICATION METHODS

#19 | 2012-10-25

US20120269727A1

Human necessities

IMAGING AGENTS WITH IMPROVED PHARMACOKINETIC PROFILES

#20 | 2012-10-04

US20120251449A1

Human necessities

ALDH: A COMPOUND FOR CANCER STEM CELL IMAGING

#21 | 2012-01-26

US20120020882A1

Chemistry; metallurgy

Peptide-based compounds

#22 | 2011-11-24

US20110286922A1

Human necessities

IMAGING AND RADIOTHERAPY METHODS

#23 | 2011-05-19

US20110117016A1

Human necessities

Diagnostic compounds

#24 | 2010-10-07

US20100256330A1

Chemistry; metallurgy

Peptide-based compounds

#25 | 2010-08-05

US20100196270A1

Chemistry; metallurgy

Radiofluorination methods

#26 | 2010-06-17

US20100150843A1

Human necessities

Peptide imaging agents

#27 | 2010-06-15

US10395500

Peptide-based compounds

#28 | 2010-05-06

US20100111865A1

Human necessities

Contrast agents

#29 | 2010-03-18

US20100068139A1

Chemistry; metallurgy

Methods of radiofluorination of biologically active vectors

#30 | 2010-02-11

US20100034740A1

Human necessities

Radiofluorination methods

#31 | 2009-10-22

US20090263320A1

Human necessities

Peptide-based compounds

#32 | 2009-09-17

US20090232741A1

Human necessities

Optical imaging

#33 | 2009-08-13

US20090203584A1

Chemistry; metallurgy

Peptide-based compounds

#34 | 2009-04-30

US20090110640A1

Chemistry; metallurgy

CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY CONSISTING OF A CYCLIC OLIGOAMID CORE OF 3 TO 4 IDENTICIAL MONOMER UNITS WITH 3 TO 4 PARAMAGNETIC CHELATE SIDE CHAINS

#35 | 2009-01-01

US20090004119A1

Human necessities

Polymers

#36 | 2008-11-13

US20080279769A1

Human necessities

Enzyme Inhibitor Imaging Agents

#37 | 2008-11-06

US20080274052A1

Chemistry; metallurgy

RADIOFLORINATION METHODS

#38 | 2008-10-30

US20080267881A1

Chemistry; metallurgy

Imaging agents

#39 | 2008-09-04

US20080213174A1

Human necessities

Radiolabelled Insulin

#40 | 2008-08-28

US20080206151A1

Human necessities

Liposomes

#41 | 2008-08-07

US20080187493A1

Human necessities

Peptide-based compounds

#42 | 2008-04-24

US20080095715A1

Human necessities

Peptide based-compounds

#43 | 2008-04-24

US20080095704A1

Human necessities

Imaging Agents with Improved Pharmacokinetic Profiles

#44 | 2008-04-24

US20080095701A1

Human necessities

Diagnostic compounds

#45 | 2008-04-01

US10269575

Peptide-based compounds

#46 | 2007-08-09

US20070183977A1

Chemistry; metallurgy

Fluorescein-labelled peptides

#47 | 2007-06-28

US20070148647A1

Chemistry; metallurgy

Purification methods

#48 | 2007-06-14

US20070134155A1

Human necessities

Pharmaceutical compounds

#49 | 2007-05-10

US20070104644A1

Human necessities

Inhibitor imaging agents

#50 | 2007-03-29

US20070071670A1

Human necessities

Diagnostic imaging agents with MMP inhibitory activity

#51 | 2007-02-15

US20070036722A1

Separation processes

#52 | 2006-10-05

US20060222593A1

Chemistry; metallurgy

Peptide-chelate conjugates

#53 | 2006-08-31

US20060193773A1

Chemistry; metallurgy

Imaging agents

#54 | 2006-08-31

US20060193768A1

Human necessities

Contrast agent

#55 | 2005-09-15

US20050201930A1

Human necessities

Contrast agents

#56 | 2005-07-26

US10370092

Contrast agents

#57 | 2005-06-14

US10052300

Process for the deprotection of protected thiols

#58 | 2005-03-31

US20050070466A1

Chemistry; metallurgy

Peptide-based compounds

#59 | 2005-01-06

US20050002865A1

Human necessities

Diagnostic/therapeutic agents

InventorID:

208820 ⎘